{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-008177","form_type":"8-K","ticker":"ECOR","cik":"0001560258","company_name":"electroCore, Inc.","filed_at":"2025-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.761724+00:00","generated_at":"2026-05-22T22:42:36.547407+00:00","sec_items":["2.01","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"electroCore completes acquisition of NeuroMetrix; $4.49/share plus CVRs","bullets":["Cash consideration of $4.49 per NURO share; each share also gets one CVR tied to Quell sales milestones.","CVR payments include 8% of Quell Net Sales up to $500K in first year, 6% in second year, plus DPNCheck proceeds.","electroCore gains Quell Fibromyalgia Solution, expects to leverage VA Hospital System distribution channel.","NURO shares to be de-listed from Nasdaq Capital Market before trading on May 2, 2025.","Transaction approved by NURO stockholders on March 21, 2025; closed May 1, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-008177","json":"https://secwatch.observer/filing/0001641172-25-008177.json","markdown":"https://secwatch.observer/filing/0001641172-25-008177.md","text":"https://secwatch.observer/filing/0001641172-25-008177.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560258/000164117225008177/0001641172-25-008177-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560258/000164117225008177/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T22:42:36.547407+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}